ArticleScientific reports2025
Pan-Immune-Inflammatory value and risk of latent tuberculosis infection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the association between the Pan-Immune-Inflammatory Value (PIV) and the risk of latent tuberculosis infection (LTBI) using a nationally representative sample from the United States. This study utilized data from 4877 adult participants in the National Health and Nutrition Examination Survey (NHANES) 2011-2012 cycle. PIV was calculated using neutrophil, monocyte, platelet, and lymphocyte counts. LTBI was assessed using the QuantiFERON-TB Gold In-Tube (QFT-GIT) test. Multivariable logistic regression was used to evaluate the association between PIV and LTBI risk. Subgroup analyses and Restricted Cubic Spline (RCS) analysis were performed. Cox regression analysis was used to examine the association of PIV with all-cause mortality among LTBI patients. Individuals with LTBI had significantly lower PIV levels compared to those without LTBI. Logistic regression analysis showed a significant negative correlation between PIV and LTBI risk, even after adjusting for covariates. The RCS analysis confirmed a dose-response relationship. The association remained significant across various demographic subgroups. Among LTBI patients, those in the highest PIV quartile had a significantly increased risk of all-cause mortality after full adjustment. PIV is negatively associated with the risk of LTBI. Additional extensive prospective investigations are required to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.